Institutional Ownership Atea Pharmaceuticals, Inc. (AVIR)
This table provides information about the institutional ownership of Atea Pharmaceuticals, Inc. (AVIR). We have compiled data on the 112 institutions that hold shares in the stock, with a total of 52.4 Million shares, which have been reported (via 13F filing form) to have a value of $170 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Private Capital Group, LLC
|
Jul 28, 2022 Q2 2022 |
156
shares
|
$525
0.0% of portfolio
|
Q2 2022
New holding
|
|
|
Nisa Investment Advisors, LLC
|
Oct 24, 2024 Q3 2024 |
128
shares
|
$431
0.0% of portfolio
|
Q3 2024
Reduced 29.67%
|
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
78
shares
|
$262
0.0% of portfolio
|
Q4 2021
Reduced 98.36%
|
|
|
Ever Source Wealth Advisors, LLC
|
Nov 08, 2024 Q3 2024 |
69
shares
|
$232
0.0% of portfolio
|
Q3 2024
Reduced 41.53%
|
|
|
Covestor LTD
Boston, MA |
Nov 01, 2024 Q3 2024 |
66
shares
|
$222
0.0% of portfolio
|
Q3 2024
Reduced 44.07%
|
|
|
Wipfli Financial Advisors Llc,
|
Oct 26, 2022 Q3 2022 |
39
shares
|
$131
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Capital Performance Advisors LLP
|
Nov 01, 2024 Q3 2024 |
31
shares
|
$104
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Cwm, LLC
|
Oct 08, 2024 Q3 2024 |
27
shares
|
$90
0.0% of portfolio
|
Q3 2024
Added 35.0%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|